Hot Topic I. Durability Issue
TAVR Is Better
[Speaker] 박덕우/울산의대
SAVR Is Better
[Speaker] 김경환/서울의대
Discussion
Hot Topic II. Optimal Age Threshold and Indication Expansion (Bicuspid, Moderate AS with HF, Asymptomatic AS)
Interventionist's Perspective
[Speaker] 고영국/연세의대
Surgeon's Perspective
[Speaker] 정성호/울산의대
Discussion